Ask AI

Nursing Management of Adverse Events With Oral Targeted Therapies for HR+/HER2− Breast Cancer: A Pocket Guide

PDF
PDF

Released: September 18, 2026

See Activity Collection

As oral targeted treatment options for HR-positive/HER2-negative breast cancer continue to expand, nurses need practical, straightforward guidance to recognize and manage complex and overlapping adverse events, support adherence, and maximize treatment benefit. This downloadable point-of-care pocket guide summarizes the indications, dosing, and administration of approved targeted agents, along with recommended strategies for adverse event monitoring and management.

Oral therapy AEs HR Positive Breast Cancer